Windward Bio and Qyuns Therapeutics Enter USD 700 Million Licensing Agreement for Immunology Therapy

Marco Zingaro Europe Legal Chronicle
Tagged:

Homburger has advised Windward Bio. Windward Bio Group AG, through its affiliate LE2025 Therapeutics AG, has entered into a licensing agreement with Qyuns Therapeutics Co., Ltd….

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Marco Zingaro

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here